Computational Characterization of Mutations in Cardiac Troponin T Known to Cause Familial Hypertrophic Cardiomyopathy

Pia J Guinto1, Edward P Manning1, Steven D Schwartz1

  • 1Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461.

Journal of Theoretical & Computational Chemistry
|October 27, 2015
PubMed

Insights

Cardiac Troponin T (cTnT) mutations increase flexibility in the TNT1 domain, impacting thin filament regulation. Molecular Dynamics simulations reveal helix opening and non-α-helical structures, explaining distant functional effects in FHC.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Cardiac Troponin T (cTnT) regulates myofilament activation.
  • The TNT1 tail domain's structure and flexibility are crucial for protein interactions in the thin filament.
  • Familial Hypertrophic Cardiomyopathy (FHC) mutations in cTnT can alter protein dynamics.

Purpose of the Study:

  • To investigate the structural dynamics of wild-type and FHC mutant cTnT using Molecular Dynamics (MD) simulations.
  • To elucidate the mechanism by which FHC mutations induce distant flexibility changes in the TNT1 domain.

Main Methods:

  • Molecular Dynamics (MD) simulations were employed to analyze wild-type and mutant cTnT segments.
  • Analysis of helical structure, dihedral angles, and Ramachandran plots was performed.

Main Results:

  • FHC mutations (Arg92Leu, Arg92Trp) induced increased flexibility in a critical hinge region of cTnT.
  • An opening of the α-helix between residues 105-110 was observed in mutants, leading to non-α-helical conformations.
  • A hypothesis suggests reduced electrostatic repulsion causes local helical compaction, resulting in distant helix expansion.

Conclusions:

  • FHC mutations in cTnT lead to significant alterations in the structural dynamics of the TNT1 domain.
  • These dynamic changes, including helix opening and altered conformations, provide insight into the functional consequences of FHC mutations.
  • Understanding these molecular mechanisms is vital for comprehending FHC pathogenesis.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
808
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
765